Home/ Supplements/ Vitamin A/ Goliath Multi Vitamin

Goliath Multi Vitamin

product on market Tablet or Pill Goliath Labs Safety: 98/100
98/100

This product looks safe

  • Vitamin B3: 120mg is 3.4× the Tolerable Upper Intake Level (35mg)
  • Manganese: 15mg is 1.4× the Tolerable Upper Intake Level (11mg)
  • 64% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains essential vitamins A, C, D, E, and thiamine, which are supported by strong evidence for maintaining immune function and cellular health. These nutrients play critical roles in metabolic processes and antioxidant defense. The ingredient profile is associated with a high safety score of 98/100.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin B3: 120mg is 3.4× the Tolerable Upper Intake Level (35mg)

Manganese: 15mg is 1.4× the Tolerable Upper Intake Level (11mg)

Label

Product Label

Label for Goliath Multi Vitamin
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Tablet(s)
Serving Size
30
Servings
Botanical with Nutrients
Product Type
64%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
20000 IU (400% DV)
Vitamin C
750 mg (1250% DV)
50 IU (13% DV)
Within RDA (0.1× RDA) 608 studies (A:16, B:251)
200 IU (667% DV)
8.9× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
50 mg (3333% DV)
41.7× RDA — above typical dose 76 studies (A:0, B:33)
25 mg (1471% DV)
19.2× RDA — above typical dose 13 studies (A:0, B:1)
120 mg (600% DV)
Exceeds UL by 3.4× (UL: 35 mg) 196 studies (A:5, B:63)
25 mg (1250% DV)
19.2× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
800 mcg (200% DV)
2.0× RDA — within safe limits 226 studies (A:10, B:105)
100 mcg (1667% DV)
41.7× RDA — above typical dose 139 studies (A:1, B:44)
300 mcg (100% DV)
10.0× RDA — above typical dose 27 studies (A:0, B:11)
150 mg (1500% DV)
30.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
300 mg (30% DV)
300 mg (75% DV)
Within RDA (0.7× RDA) 316 studies (A:8, B:159)
20 mg (133% DV)
1.8× RDA — within safe limits 263 studies (A:6, B:134)
200 mcg (286% DV)
3.6× RDA — above typical dose (UL: 0.4 mg) 173 studies (A:0, B:67)
2 mg (100% DV)
2.2× RDA — within safe limits 37 studies (A:0, B:11)
15 mg (750% DV)
Exceeds UL by 1.4× (UL: 11 mg) 9 studies — no high-quality reviews
200 mcg (167% DV)
5.7× RDA — above typical dose 199 studies (A:1, B:55)
50 mcg (67% DV)
1.1× RDA — within safe limits 3 studies — no high-quality reviews
Potassium
75 mg (2% DV)
Stress Proprietary Blend
405.78 mg
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
50 mg
Market median: 500.0mg (9 products) 7 studies — no high-quality reviews
25 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
20 mg
Market median: 125.0mg (294 products) 38 studies (A:1, B:7)
1 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
25 mcg
Market median: 0.5mg (6 products) 1 studies (A:0, B:1)

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Stearic Acid Magnesium Stearate Pharmaceutical Glaze
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

SUGGESTED USE: As a dietary supplement, adults take four (4) tablets daily preferably with a meal.

Warnings & Precautions

Seek advice from a health care practitioner to use if you have high blood pressure, heart or thyroid disease, diabetes, difficulty in urination due to prostate enlargement, or if you are pregnant, nursing, or taking a MAO inhibitor or any prescription drug.

Reduce or discontinue if nervousness, tremors, sleeplessness, loss of appetite or nausea occur,

Not intended for use by persons under 18 years of age.

Do not exceed recommended serving size.

Keep Out Of Reach Of Children. Must Be 18 Years Of Age To Use Or Buy.

Additional Information

NEW & IMPROVED

This product is a dietary supplement intended for nutritional support.

ULTIMATE PERFORMANCE

MTV_004_USA

EXECUTIVE MATRIX

Metadata

Product Details

UPC / SKU6 89076 07017 1
DSLD Entry Date2012-10-01
Product TypeBotanical with Nutrients
FormTablet or Pill
DSLD ID12360
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.